Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,475,691 papers from all fields of science
Search
Sign In
Create Free Account
Serum Bactericidal Antibody Assay
Known as:
Serum Bactericidal Antibody Assays
Procedures for identification and measurement of IMMUNOGLOBULINS in the blood that initiate lysis of bacteria.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Bactericidal Antibody Assay
Blood Bactericidal Activity
standards characteristics
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Immunogenicity, safety and inter-lot consistency of a meningococcal conjugate vaccine (MenACYW-TT) in adolescents and adults: A Phase III randomized study.
M. S. Dhingra
,
James T Peterson
,
J. Hedrick
,
Judy Pan
,
D. Neveu
,
E. Jordanov
Vaccine
2020
Corpus ID: 219975714
2020
2020
Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age
T. Vesikari
,
P. Peyrani
,
+7 authors
John L. Perez
Human Vaccines & Immunotherapeutics
2020
Corpus ID: 220268520
ABSTRACT This phase 3B, open-label, extension study (NCT01962207) evaluated long-term persistence of antibodies induced by the…
Expand
2016
2016
Pooled-sera hSBA titres predict individual seroprotection in infants and toddlers vaccinated with 4CMenB.
S. Budroni
,
A. Kleinschmidt
,
P. Boucher
,
D. Medini
Vaccine
2016
Corpus ID: 205601263
2016
2016
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
C. Robertson
,
D. Greenberg
,
J. Hedrick
,
M. Pichichero
,
M. Decker
,
M. Saunders
Vaccine
2016
Corpus ID: 205602482
2016
2016
Safety and immunogenicity of a CRM or TT conjugated meningococcal vaccine in healthy toddlers.
G. Bona
,
P. Castiglia
,
+5 authors
I. Smolenov
Vaccine
2016
Corpus ID: 22850885
Highly Cited
2013
Highly Cited
2013
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
G. Frosi
,
A. Biolchi
,
+8 authors
D. Medini
Vaccine
2013
Corpus ID: 6217868
Highly Cited
2010
Highly Cited
2010
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease.
Hanming Jiang
,
S. Hoiseth
,
+20 authors
A. Anderson
Vaccine
2010
Corpus ID: 22514823
Highly Cited
2010
Highly Cited
2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
J. Findlow
,
R. Borrow
,
+10 authors
A. Pollard
Clinical Infectious Diseases
2010
Corpus ID: 7254772
BACKGROUND In the absence of an efficacious broadly protective vaccine, serogroup B Neisseria meningitidis (MenB) is the leading…
Expand
2006
2006
Immunoglobulin G Subclass Response to a Meningococcal Quadrivalent Polysaccharide-Diphtheria Toxoid Conjugate Vaccine
H. Findlow
,
J. Southern
,
+6 authors
R. Borrow
Clinical and Vaccine Immunology
2006
Corpus ID: 20301367
ABSTRACT Changes in the immunoglobulin G1 (IgG1)/IgG2 ratio following vaccination can indicate the activation of cellular control…
Expand
Highly Cited
2003
Highly Cited
2003
Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England
N. Andrews
,
R. Borrow
,
E. Miller
Clinical Diagnostic Laboratory Immunology
2003
Corpus ID: 36661432
ABSTRACT Meningococcal C conjugate (MCC) vaccines were licensed on the basis of serological correlates of protection without…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE